On Dec 31, , A.S. Ducloy-Bouthors and others published Thalassémie } Welke behandeling van een anemie bij ß-thalassemie minor heeft de voorkeur. thalassemie NAO, thalassemieën, anemie; thalassemie, hemoglobinopathie; met thalassemie, leptocytose; hereditair, thalassemie; aandoening hemoglobine, . Relatie van de determinant met ongezondheid Bloedarmoede (anemie) ( bijvoorbeeld sikkelcellen* en thalassemie*) en intoxicaties (bijvoorbeeld lood).
|Published (Last):||15 July 2012|
|PDF File Size:||2.26 Mb|
|ePub File Size:||16.13 Mb|
|Price:||Free* [*Free Regsitration Required]|
Hemoglobin is a protein that carries oxygen to the body. Definition MSH A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains.
InfancyNeonatal ICD Hematology and Oncology Chapters. People with it may have severe anemia, slowed growth an,ie delayed puberty, and problems with the spleen, liver, heart, or bones. Splenectomy may be required.
You are currently viewing the original ‘fpnotebook. Please Contact Me as you run across problems with any of these versions on the website.
The most common severe type in the United States is called Cooley’s anemia.
Management and treatment Treatment is based on lifelong transfusions to correct anemia, suppress erythropoiesis, and inhibition of gastrointestinal iron absorption, which occurs in non-transfused patients due to anmle, although ineffective, erythropoiesis.
Some people have no symptoms or mild anemia.
Thalassemias are inherited blood disorders. Another, mobile version is also available which should function on both newer and older web browsers. Treatments include blood transfusions and treatment to remove excess iron from the body.
Health care resources for this disease Expert centres Diagnostic tests Patient organisations 46 Orphan drug s Genetic counseling Transmission is autosomal recessive. Onset is during infancy with severe anemia, failure to thrive and progressive pallor. Related links to external sites from Bing. National Heart, Lung, and Blood Institute. Definition MSH A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more thalasemie polypeptide chains.
Treatment is based on lifelong transfusions to correct anemia, suppress erythropoiesis, and inhibition of gastrointestinal iron absorption, which occurs in non-transfused patients due to increased, although ineffective, erythropoiesis. Diagnosis is suspected in infants younger than 2 thalasssemie of age with severe microcytic anemia, mild jaundice and hepatosplenomegaly. Later-onset iron overload complications include dilated myocardiopathy, arrhythmias, liver fibrosis and cirrhosis, diabetes mellitus, and insufficiency of the parathyroid, thyroid, pituitary, and, less commonly, adrenal glands.
Related Topics in Hemoglobinopathies. Other search option s Alphabetical list.
Some people have no symptoms or mild anemia. Background Thalassemia is derived from Greek word “thalassa” for sea Epidemiology Thalassemia accounts for one third of all globin abnormalities Gender: Detailed information Article for general public Svenska Other complications are hypersplenism, venous thrombosis and osteoporosis. Clinical description Onset is during infancy with severe anemia, failure to thrive and progressive pallor. It usually appears during the first two years of life.
Males and females affected equally Prevalence of Thalassemia World wide: Patients who do not receive regular transfusions and iron chelation usually die before the 2nd or 3rd decade whereas survival is higher wnmie regularly transfused and chelated patients. Both disease-causing alleles must be identified before prenatal testing can be performed.